Study to Assess Efficacy and Safety of Lanreotide Autogel 120 MG in Treatment of Clinical Symptoms Associated With Inoperable Malignant Intestinal Obstruction

- 18 December 2024 - 1 mins read

To assess the efficacy of Lanreotide Autogel 120 mg for the relief of vomiting due to inoperable malignant intestinal obstruction in patients without nasogastric tube (NGT) and to assess the efficacy of lanreotide Autogel 120 mg on removal of nasogastric tube without the recurrence of vomiting in patients with an inoperable malignant intestinal obstruction with a nasogastric tube.

Related Clinical Trials

18 December 2024 1 mins read

Which is the Best Dose of Dysport in Helping With Hip Pain for Children With Cerebral Palsy?

18 December 2024 1 mins read

Study to Assess Impact of Dysport Injections Early After Stroke on Upper Limb Spasticity Progression

18 December 2024 1 mins read

Efficacy and Safety Study of Botulinum Toxin Type-A (Dysport®) in Continent Female Subjects Suffering From Idiopathic Overactive Bladder

18 December 2024 1 mins read

Efficacy and Safety of Botulinum Toxin Type A Haemagglutinin Complex Next Generation (BTX-A-HAC NG) in Glabellar Lines

18 December 2024 1 mins read

Efficacy and Safety of Clostridium Botulinum Toxin Type A to Improve Appearance of Moderate to Severe Glabellar Lines

18 December 2024 1 mins read

Study to Assess Efficacy and Safety of Lanreotide Autogel 120 MG in Treatment of Clinical Symptoms Associated With Inoperable Malignant Intestinal Obstruction

Study to Assess Efficacy and Safety of Lanreotide Autogel 120 MG in Treatment of Clinical Symptoms Associated With Inoperable Malignant Intestinal Obstruction

Related Clinical Trials

Which is the Best Dose of Dysport in Helping With Hip Pain for Children With Cerebral Palsy?

Study to Assess Impact of Dysport Injections Early After Stroke on Upper Limb Spasticity Progression

Efficacy and Safety Study of Botulinum Toxin Type-A (Dysport®) in Continent Female Subjects Suffering From Idiopathic Overactive Bladder

Dysport® Pediatric Lower Limb Spasticity Follow-on Study

Dysport® Adult Lower Limb Spasticity Follow-on Study

Dysport® Pediatric Lower Limb Spasticity Study

Dysport® Adult Lower Limb Spasticity Study

Efficacy and Safety of Botulinum Toxin Type A Haemagglutinin Complex Next Generation (BTX-A-HAC NG) in Glabellar Lines

Efficacy and Safety of Clostridium Botulinum Toxin Type A to Improve Appearance of Moderate to Severe Glabellar Lines

Dysport in the Treatment of Glabellar Lines in Chinese Subjects